Document is current
Any future updates will be listed below
-
Authors
Avdeeva, Maria
Walker, Sarah K. https://orcid.org/0000-0002-3179-5569
van der Veeken, Joris https://orcid.org/0000-0001-7299-2174
Rudensky, Alexander Y. https://orcid.org/0000-0003-1280-2898
Pritykin, Yuri https://orcid.org/0000-0001-6589-981X
- License Information
-
More Information
Article History
Received: 30 September 2025
Accepted: 26 May 2026
First Online: 6 June 2026
Competing interests
: A.Y.R. is an SAB member and has equity in Sonoma Biotherapeutics, RAPT Therapeutics, Coherus BioSciences, Santa Ana Bio, Odyssey Therapeutics, Nilo Therapeutics, and Vedanta Biosciences; he is also an SAB member of BioInvent and Amgen and a co-inventor of a CCR8+ Treg cell depletion IP licensed to Takeda, which is unrelated to the content of this publication. The remaining authors declare no competing interests.
